Fingerprint
Dive into the research topics of 'Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
Yuan Hung Kuo, Yi Hao Yen, Yen Yang Chen, Kwong Ming Kee, Chao Hung Hung, Sheng Nan Lu, Tsung Hui Hu, Chien Hung Chen, Jing Houng Wang*
*Corresponding author for this work
Research output: Contribution to journal › Journal Article › peer-review
15
Scopus
citations